Ahini RT, di Giovine FS, McDonagh AJGInterleukin 1 composite genotypes
as determinants for subtypes of alopecia areata.J Invest Dermatol,
1999; Symp Proc 4 (3) 53.
Anderson R. Dithranol-mediated, dose-dependent priming and activation
of luminol-enhanced chemiluminescence responses of human neutrophils
in vitro.Br J Dermatol. 1989 Jul;121(1):1-9.
Assouly P.PeladeEncycl Méd Chir (Elsevier, Paris) Dermatologie, 1999;
98-810-C-10 ; 1-11.
Atkin DH, Levine N, Walter FG. Single patch of hair at a denervated
site in a patient with alopecia universalis.J Am Acad Dermatol. 1997
Nov;37(5 Pt 1):796-7.
Baadsgaard O, Lindskov R, Clemmensen OJ. In situ lymphocyte subsets
in alopecia areata before and during treatment with a contact allergen.Clin
Exp Dermatol. 1987 Jul;12(4):260-4.
Brocker EB, Echternacht-Happle K, Hamm H, Happle R. Abnormal expression
of class I and class II major histocompatibility antigens in alopecia
areata: modulation by topical immunotherapy.J Invest Dermatol. 1987
May;88(5):564-8.
Camacho FM, Garcia-Hernandez MJ. Zinc aspartate, biotin, and clobetasol
propionate in the treatment of alopecia areata in childhood.Pediatr
Dermatol. 1999 Jul-Aug;16(4):336-8.
Carter DM, Jegasothy BV. Alopecia areata and Down syndrome.Arch Dermatol.
1976 Oct;112(10):1397-9.
Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II
antigen associations help to define two types of alopecia areata.J
Am Acad Dermatol. 1995 Nov;33(5 Pt 1):757-64.
Cork MJ, Tarlow JK, Clay FE, Crane A, Blakemore AI, McDonagh AJ,
Messenger AG, Duff GW. An allele of the interleukin-1 receptor antagonist
as a genetic severity factor in alopecia areata.J Invest Dermatol.
1995 May;104(5 Suppl):15S-16S.
Daly TJ. Alopecia areata has low plasma levels of the vasodilator/immunomodulator
calcitonin gene-related peptide.Arch Dermatol. 1998 Sep;134(9):1164-5.
Dressel D, Brutt CH, Manfras B, Zollner TM, Wunderlich A, Bohm BO,
Boehncke WH. Related Articles Alopecia areata but not androgenetic
alopecia is characterized by a restricted and oligoclonal T-cell receptor-repertoire
among infiltrating lymphocytes.J Cutan Pathol. 1997 Mar;24(3):164-8.
Duvic M, Welsh EA, Jackow C, Papadopoulos E, Reveille JD, Amos C.
Analysis of HLA-D locus alleles in alopecia areata patients and families.J
Invest Dermatol. 1995 May;104(5 Suppl):5S-6S.
Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille
JD. HLA-D locus associations in alopecia areata. DRw52a may confer
disease resistance.Arch Dermatol. 1991 Jan;127(1):64-8.
Du Vivier A, Munro DD. Alopecia areata, autoimmunity, and Down's
syndrome.Br Med J. 1975 Jan 25;1(5951):191-2.
Ericson M, Gabrielson A, Worel S, Lee WS, Hordinsky MK. Substance
P (SP) in innervated and non-innervated blood vessels in the skin
of patients with symptomatic scalp.Exp Dermatol. 1999 Aug;8(4):344-5.
Fenton DA, Tobin DJ, Kendall MD. Role of the thymus gland in alopecia
areata.J Invest Dermatol. 1995 May;104(5 Suppl):25S-26S. Fiedler VC.
Alopecia areata. A review of therapy, efficacy, safety, and mechanism.Arch
Dermatol. 1992 Nov;128(11):1519-29.
Fiedler VC. Alopecia areata: current therapy.J Invest Dermatol. 1991
May;96(5):69S-70S.Fiedler VC, Buys CM. Direct T-cell effects of minoxidil.Clin
Dermatol. 1988 Oct-Dec;6(4):148-51.
Fiedler-Weiss VC, Buys CM. Evaluation of anthralin in the treatment
of alopecia areata.Arch Dermatol. 1987 Nov;123(11):1491-3.
Freyschmidt-Paul P, Seiter S, Zoller M, Konig A, Ziegler A, Sundberg
JP, Happle R, Hoffmann R. Treatment with an anti-CD44v10-specific
antibody inhibits the onset of alopecia areata in C3H/HeJ mice.J Invest
Dermatol. 2000 Oct;115(4):653-7.
Freyschmidt-Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess
D, Hoffmann R. Successful treatment of alopecia areata-like hair loss
with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ
mice.J Invest Dermatol. 1999 Jul;113(1):61-8.
Galbraith GM, Palesch Y, Gore EA, Pandey JP. Contribution of interleukin
1beta and KM loci to alopecia areata.Hum Hered. 1999 Mar;49(2):85-9.Galbraith
GM, Pandey JP. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism
in alopecia areata.Hum Genet. 1995 Oct;96(4):433-6.
Garcia-Hernandez MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho
F. Alopecia areata, stress and psychiatric disorders: a review.J Dermatol.
1999 Oct;26(10):625-32.
Geletko SM, Segarra M, Mikolich DJ. Alopecia associated with zidovudine
therapy.Pharmacotherapy. 1996 Jan-Feb;16(1):79-81.
Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish RS. Alopecia
areata is a T-lymphocyte mediated autoimmune disease: lesional human
T-lymphocytes transfer alopecia areata to human skin grafts on SCID
mice.J Investig Dermatol Symp Proc. 1999 Dec;4(3):207-10.
Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS. Autoimmune hair
loss (alopecia areata) transferred by T lymphocytes to human scalp
explants on SCID mice.J Clin Invest. 1998 Jan 1;101(1):62-7.
Gilhar A, Pillar T, Assay B, David M. Failure of passive transfer
of serum from patients with alopecia areata and alopecia universalis
to inhibit hair growth in transplants of human scalp skin grafted
on to nude mice.Br J Dermatol. 1992 Feb;126(2):166-71.
Gilhar A, Krueger GG. Hair growth in scalp grafts from patients with
alopecia areata and alopecia universalis grafted onto nude mice.Arch
Dermatol. 1987 Jan;123(1):44-50.
Groves RW, Mizutani H, Kieffer JD, Kupper TS. Inflammatory skin disease
in transgenic mice that express high levels of interleukin 1 alpha
in basal epidermis.Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11874-8.
Hamm H, Klemmer S, Kreuzer I, Steijlen PM, Happle R, Brocker EB.
HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs
in long-standing alopecia areata.Arch Dermatol Res. 1988;280(3):179-81.
Happle R, Hoffmann R. Cytokine patterns in alopecia areata before
and after topical immunotherapy.J Invest Dermatol. 1995 May;104(5
Suppl):14S-15S.
Hay IC, Jamieson M, Ormerod AD. Randomized trial of aromatherapy.
Successful treatment for alopecia areata.Arch Dermatol. 1998 Nov;134(11):1349-52.Heyl
T. Tick bite alopecia.Clin Exp Dermatol. 1982 Sep;7(5):537-42.
Hoffmann R. The potential role of cytokines and T cells in alopecia
areata.J Investig Dermatol Symp Proc. 1999 Dec;4(3):235-8.
Hoffmann R, Wenzel E, Huth A, van der Steen P, Schaufele M, Konig
A, Happle R. Growth factor mRNA levels in alopecia areata before and
after treatment with the contact allergen diphenylcyclopropenone.Acta
Derm Venereol. 1996 Jan;76(1):17-20.
Happle R, Hoffmann R. Cytokine patterns in alopecia areata before
and after topical immunotherapy.J Invest Dermatol. 1995 May;104(5
Suppl):14S-15S.
Hoffmann R, Wenzel E, Huth A, van der Steen P, Schaufele M, Henninger
HP, Happle R. Cytokine mRNA levels in Alopecia areata before and after
treatment with the contact allergen diphenylcyclopropenone.J Invest
Dermatol. 1994 Oct;103(4):530-3.
Hordinsky MK, Kennedy W, Wendelschafer-Crabb G, Lewis S. Structure
and function of cutaneous nerves in alopecia areata.J Invest Dermatol.
1995 May;104(5 Suppl):28S-29S.
Ishida Y, Nishi M, Taguchi O, Inaba K, Minato N, Kawaichi M, Honjo
T. Effects of the deregulated expression of human interleukin-2 in
transgenic mice.Int Immunol. 1989;1(2):113-20.
Kavak A, Baykal C, Ozarmagan G, Akar U. HLA in alopecia areata.Int
J Dermatol. 2000 Aug;39(8):589-92.
Kohchiyama A, Hatamochi A, Ueki H. Increased number of OKT6-positive
dendritic cells in the hair follicles of patients with alopecia areata.Dermatologica.
1985;171(5):327-31.
Lei Y, Nie Y, Zhang JM, Liao DY, Li HY, Man MQ. Effect of superficial
hypothermic cryotherapy with liquid nitrogen on alopecia areata.Arch
Dermatol. 1991 Dec;127(12):1851-2.
Lotti T, Teofoli P, Senesi C, Fedi AM, Bonan P, Palleschi GM, Panconesi
E. The role of plasminogen activators in alopecia areata.Int J Dermatol.
1991 Jan;30(1):19-21.
MacDonald N. Alopecia areata: identification and current treatment
approaches.Dermatol Nurs. 1999 Oct;11(5):356-9, 363-6. Madani S, Shapiro
J. Alopecia areata update.J Am Acad Dermatol. 2000 Apr;42(4):549-66;
quiz 567-70.
Mcdonagh AJ, Snowden JA, Stierle C, Elliott K, Messenger AG. HLA
and ICAM-1 expression in alopecia areata in vivo and in vitro: the
role of cytokines.Br J Dermatol. 1993 Sep;129(3):250-6.
McElwee KJ, Spiers EM, Oliver RF. Partial restoration of hair growth
in the DEBR model for Alopecia areata after in vivo depletion of CD4+
T cells.Br J Dermatol. 1999 Mar;140(3):432-7.
McElwee KJ, Boggess D, King LE Jr, Sundberg JP. Experimental induction
of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness
skin grafts.J Invest Dermatol. 1998 Nov;111(5):797-803.
McElwee KJ, Spiers EM, Oliver RF. In vivo depletion of CD8+ T cells
restores hair growth in the DEBR model for alopecia areata.Br J Dermatol.
1996 Aug;135(2):211-7.
Michie HJ, Jahoda CA, Oliver RF, Johnson BE. The DEBR rat: an animal
model of human alopecia areata.Br J Dermatol. 1991 Aug;125(2):94-100.
Mijailovic B, Spasic P, Jankovic D, Karadaglic D, Stankovic K, Bursac
P. [Electron microscopy of blood vessels in alopecia areata].Vojnosanit
Pregl. 1989 Mar-Apr;46(2):105-7.
Montazeri A, Serre G, Kanitakis J.Alopecia Areata : a reviewEur J
Dermatol. 1996 Jun;6:471-478.
Muller SA, Winkelmanm RK.Alopecia areata. Arch Dermatol. 1963; 88:290.
Nickoloff BJ, Griffiths CE. Aberrant intercellular adhesion molecule-1
(ICAM-1) expression by hair-follicle epithelial cells and endothelial
leukocyte adhesion molecule-1 (ELAM-1) by vascular cells are important
adhesion-molecule alterations in alopecia areata.J Invest Dermatol.
1991 May;96(5):91S-92S.
Nutbrown M, MacDonald Hull SP, Baker TG, Cunliffe WJ, Randall VA.
Ultrastructural abnormalities in the dermal papillae of both lesional
and clinically normal follicles from alopecia areata scalps.Br J Dermatol.
1996 Aug;135(2):204-10.
Nutbrown M, Hull SP, Cunliffe WJ, Randall VA. Abnormalities in the
ultrastructure of melanocytes and the outer root sheath of clinically
normal hair follicles from alopecia areata scalps.J Invest Dermatol.
1995 May;104(5 Suppl):12S-13S.
Odum N, Morling N, Georgsen J, Jakobsen BK, Frentz G, Jensen GF,
Fugger L, Svejgaard A. HLA-DP antigens in patients with alopecia areata.Tissue
Antigens. 1990 Mar;35(3):114-7.
Ohta M, Mitomi T, Kimura M, Habu S, Katsuki M. Anomalies in transgenic
mice carrying the human interleukin-2 gene.Tokai J Exp Clin Med. 1990
Jul;15(4):307-15.
Orecchia G, Capelli E, Martinetti M, Cuccia Belvedere M, Rabbiosi
G. Decreased in vitro lymphocyte stimulation and reduced sensitivity
to IL-2 in patients with alopecia areata.Arch Dermatol Res. 1988;280
Suppl:S47-50.
Orecchia G, Belvedere MC, Martinetti M, Capelli E, Rabbiosi G. Human
leukocyte antigen region involvement in the genetic predisposition
to alopecia areata.Dermatologica. 1987;175(1):10-4.
Parameshwar E. Hair loss associated with fluvoxamine use.Am J Psychiatry.
1996 Apr;153(4):581-2.
Paus R, Heinzelmann T, Schultz KD, Furkert J, Fechner K, Czarnetzki
BM. Hair growth induction by substance P.Lab Invest. 1994 Jul;71(1):134-40.
Philpott MP, Sanders DA, Bowen J, Kealey T. Effects of interleukins,
colony-stimulating factor and tumour necrosis factor on human hair
follicle growth in vitro: a possible role for interleukin-1 and tumour
necrosis factor-alpha in alopecia areata.Br J Dermatol. 1996 Dec;135(6):942-8.
Price VH, Colombe BW. Heritable factors distinguish two types of
alopecia areata.Dermatol Clin. 1996 Oct;14(4):679-89.Price VH. Alopecia
areata: clinical aspects.J Invest Dermatol. 1991 May;96(5):68S.
Price VH. Double-blind, placebo-controlled evaluation of topical
minoxidil in extensive alopecia areata.J Am Acad Dermatol. 1987 Mar;16(3
Pt 2):730-6.
Roselino AM, Almeida AM, Hippolito MA, Cerqueira BC, Maffei CM, Menezes
JB, Vieira RE, Assis SL, Ali SA. Clinical-epidemiologic study of alopecia
areata.Int J Dermatol. 1996 Mar;35(3):181-4.
Rossi R, Del Bianco E, Isolani D, Baccari MC, Cappugi P. Possible
involvement of neuropeptidergic sensory nerves in alopecia areata.Neuroreport.
1997 Mar 24;8(5):1135-8.
Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence
of alopecia areata in Olmsted County, Minnesota, 1975 through 1989.Mayo
Clin Proc. 1995 Jul;70(7):628-33.
Safavi K. Prevalence of alopecia areata in the First National Health
and Nutrition Examination Survey. Arch Dermatol. 1992 May;128(5):702.
Sawaya ME, Bakshandeh H, Hordinsky MK, Penneys NS. CD44 expression
in alopecia areata and androgenetic alopecia. J Cutan Pathol. 1994
Jun;21(3):229-32.
Schmoeckel C, Weissmann I, Plewig G, Braun-Falco O. Treatment of
alopecia areata by anthralin-induced dermatitis. Arch Dermatol. 1979
Oct;115(10):1254-5.
Shapiro R, Jordan ML, Scantlebury VP, Vivas C, McCauley J, Johnston
J, Fung JJ, Starzl TE. Alopecia as a consequence of tacrolimus therapy.
Transplantation. 1998 May 15;65(9):1284.
Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire
analysis of patient and family. Int J Dermatol. 1992 Mar;31(3):186-9.
Shenefelt PD. Hypnosis in dermatology. Arch Dermatol. 2000 Mar;136(3):393-9.
Skinner RB Jr, Light WH, Bale GF, Rosenberg EW, Leonardi C. Alopecia
areata and presence of cytomegalovirus DNA. JAMA. 1995 May 10;273(18):1419-20.
Skoutelis A, Freinkel RK, Kaufman DS, Leibovich SJ. Angiogenic activity
is defective in monocytes from patients with alopecia universalis.
J Invest Dermatol. 1990 Aug;95(2):139-43.
Smyth JR Jr, McNeil M. Alopecia areata and universalis in the Smyth
chicken model for spontaneous autoimmune vitiligo. J Investig Dermatol
Symp Proc. 1999 Dec;4(3):211-5.
Spickett G, Prentice AG, Wallington T, Webster AD, Chapel H. Alopecia
totalis and vitiligo in common variable immunodeficiency. Postgrad
Med J. 1991 Mar;67(785):291-4.
Sundberg JP, Cordy WR, King LE Jr. Alopecia areata in aging C3H/HeJ
mice. J Invest Dermatol. 1994 Jun;102(6):847-56.
Tasaki M, Hanada K, Hashimoto I. Analyses of serum copper and zinc
levels and copper/zinc ratios in skin diseases. J Dermatol. 1993 Jan;20(1):21-4.
Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting
cytokine profiles in localized form and extensive form (alopecia universalis).
Acta Derm Venereol. 1996 Nov;76(6):421-3.
Thiers BH. Isoprinosine treatment of alopecia areata. J Invest Dermatol.
1991 May;96(5):72S-73S. Tobin DJ, Hann SK, Song MS, Bystryn JC. Hair
follicle structures targeted by antibodies in patients with alopecia
areata. Arch Dermatol. 1997 Jan;133(1):57-61.
Tobin DJ, Orentreich N, Fenton DA, Bystryn JC. Antibodies to hair
follicles in alopecia areata. J Invest Dermatol. 1994 May;102(5):721-4.
Ushigome H, Yoshimura N, Okamoto M, Najima H, Hamajima T, Nakai I,
Oka T. Two cases of tacrolimus-induced alopecia following kidney transplantation.
Transplant Proc. 1999 Nov;31(7):2885-6.
Valsecchi R, Imberti G, Martino D, Cainelli T. Alopecia areata and
interleukin-2 receptor. Dermatology. 1992;184(2):126-8.
Wagner SN, Wagner C, Reinhold U, Funk R, Zoller M, Goos M. Predominant
expression of CD44 splice variant v10 in malignant and reactive human
skin lymphocytes. J Invest Dermatol. 1998 Sep;111(3):464-71.
Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI. Increased
risk for type I (insulin-dependent) diabetes in relatives of patients
with alopecia areata (AA). Am J Med Genet. 1994 Jul 1;51(3):234-9.
Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M. Human leukocyte
antigen-DQB1*03 alleles are associated with alopecia areata. J Invest
Dermatol. 1994 Dec;103(6):758-63.
Wise RP, Kiminyo KP, Salive ME. Hair loss after routine immunizations.
JAMA. 1997 Oct 8;278(14):1176-8
Yanagisawa H, Richardson JA, Taurog JD, Hammer RE. Characterization
of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats.
Am J Pathol. 1995 Oct;147(4):955-64.
